Pharmarise Holdings Corporation

TSE:2796.T

616 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q2
Revenue 13,79213,72613,47713,47113,30012,98512,88412,86113,02912,67612,84113,06213,86512,79312,78512,88112,43712,83212,84812,91313,21812,85112,76912,89013,62713,70313,63613,59614,99712,71612,56312,67313,445.62713,702.44310,977.85810,385.64210,280.0679,918.429,865.5989,441.99710,402.7649,424.6069,251.2889,142.3819,887.9158,473.2377,537.3267,458.5887,678.6937,688.6087,164.2097,075.5477,161.0086,717.5986,575.5246,370.8696,517.346,274.4415,376.4715,248.6445,264.8775,059.184,934.464
Cost of Revenue 11,93911,68211,33611,34111,17910,95810,99610,76310,97910,75510,73411,02311,63010,75510,67311,19810,61210,93310,94711,10011,18011,07510,97011,16111,72611,64311,61111,63212,96310,96610,82010,98211,725.33711,839.7559,290.3538,726.2148,540.0318,366.8048,202.7298,020.7368,584.1528,021.4397,867.0717,735.6218,322.5037,248.0356,466.5666,377.7566,535.6966,514.1946,095.9976,009.4395,991.7095,734.0955,449.8685,546.085,506.6575,455.7984,666.0054,595.0244,568.3744,358.9384,362.535
Gross Profit 1,8532,0442,1412,1302,1212,0271,8882,0982,0501,9212,1072,0392,2352,0382,1121,6831,8251,8991,9011,8132,0381,7761,7991,7291,9012,0602,0251,9642,0341,7501,7431,6911,720.291,862.6881,687.5051,659.4281,740.0361,551.6161,662.8691,421.2611,818.6121,403.1671,384.2171,406.761,565.4121,225.2021,070.761,080.8321,142.9971,174.4141,068.2121,066.1081,169.299983.5031,125.656824.7891,010.683818.643710.466653.62696.503700.242571.929
Gross Profit Ratio 0.1340.1490.1590.1580.1590.1560.1470.1630.1570.1520.1640.1560.1610.1590.1650.1310.1470.1480.1480.140.1540.1380.1410.1340.140.150.1490.1440.1360.1380.1390.1330.1280.1360.1540.160.1690.1560.1690.1510.1750.1490.150.1540.1580.1450.1420.1450.1490.1530.1490.1510.1630.1460.1710.1290.1550.130.1320.1250.1320.1380.116
Reseach & Development Expenses 333313433103226000900013000130008000700070001300014000000000000000000
General & Administrative Expenses 000000000000292000271000368000349000359000427000458000454000362000000000000000000
Selling & Marketing Expenses 0000000000001,2640001,1210009880001,1920009220001,1260001,014000283000183000000000000000000
SG&A 1,7971,8891,6181,7991,3881,5461,4951,5841,5401,7081,6361,7211,5561,8021,5711,6971,3921,6551,5001,7071,3561,6691,6121,7411,5411,6861,5901,8121,2811,6491,5421,6841,5531,6361,4041,4431,4721,3061,2881,2737371,0331,0331,0245459137400000000000000000
Other Expenses 3-40117012128-3212-316-1711141364-721141-40101311012244-87649.03717.6532.4567.35848.1754.655-2.54612.969-52.05-38.1311.79-14.77844.9184.619-10.055-11.102-24.232-12.492-29.474-4.162-5.306-4.964-21.023-8.347-40.713-12.523-48.033-13.952-16.214-17.503-15.008
Operating Expenses 1,8001,8921,7611,7991,5791,7041,6631,7491,5311,7081,6361,7211,7501,8021,5711,6981,5541,6551,4861,7071,6801,6691,6121,7411,6811,6861,5911,8131,8631,6491,5431,7201,633.4431,636.2641,403.1871,443.8631,364.7411,305.9951,288.641,273.0861,349.5171,032.5631,033.7521,024.241,105.637912.968740.51771.374745.179734.277645.467669.503643.103660.803620.731681.828621.648592.121469.167527.632513.681495.345476.612
Operating Income 53152379331542323225348520212471317485236540-15269244416105359107186-12221374434150171100200-2986.848226.424284.318215.564375.295245.62374.229148.175469.095370.604350.465382.519459.776312.233330.25309.457397.818440.137422.745396.604526.196322.699504.923142.96389.035226.521241.298125.987182.822204.89595.317
Operating Income Ratio 0.0040.0110.0280.0250.0410.0250.0170.0270.040.0170.0370.0240.0350.0180.042-0.0010.0220.0190.0320.0080.0270.0080.015-0.0010.0160.0270.0320.0110.0110.0080.016-0.0020.0060.0170.0260.0210.0370.0250.0380.0160.0450.0390.0380.0420.0460.0370.0440.0410.0520.0570.0590.0560.0730.0480.0770.0220.060.0360.0450.0240.0350.040.019
Total Other Income Expenses Net -671-53-29-20-2135-149-30-164-209-25172-161-7116-18733-8927-141-17-58-24-533-113-93-26-204-160-9214-121.049-50.145438.156-55.323-37.77-49.075-62.261-50.76-158.447-98.874-99.366-59.90854.58-111.664361.861-85.347-67.101-40.411-79.685-34.584-127.916-37.583-109.487-49.654-235.836-36.972-93.623-35.769-35.809-19.062-38.236
Income Before Tax -61899350312327328763183551924822936567547018327732713221890128-36-312260341125-33-59108-15-34.202176.279722.474160.242337.525196.546311.96897.415310.648271.73251.099322.612514.355200.57692.111224.111330.717399.726343.06362.021398.28285.117395.43893.307153.199189.55147.67690.219147.013185.83557.081
Income Before Tax Ratio -0.0450.0070.0260.0230.0250.0250.0060.0250.0270.0150.0380.0220.0470.0060.03700.0070.0220.0250.010.0160.0070.01-0.003-0.0230.0190.0250.009-0.002-0.0050.009-0.001-0.0030.0130.0660.0150.0330.020.0320.010.030.0290.0270.0350.0520.0240.0920.030.0430.0520.0480.0510.0560.0420.060.0150.0240.030.0270.0170.0280.0370.012
Income Tax Expense -881941941851991861142032221212902303429229256210165192-329111861357743193228158-152132159112258.04498.153149.585149.706248.715151.838203.254111.096215.337182.557198.919182.067244.514152.251149.595120.604208.211222.626169.449139.449202.929139.525192.15364.06774.77297.20375.98648.97647.781105.43223.841
Net Income -528-97150123125136-391111257218763312-13182-55-1281101334621337-3-114-26690154-6237-119-10-101-279.83673.091572.87516.06586.17844.819108.404-11.50988.43287.97251.773140.917268.37145.912541.473102.245117.683174.621172.074221.44189.378143.506202.15327.9474.49190.3970.77840.91697.91479.60632.841
Net Income Ratio -0.038-0.0070.0110.0090.0090.01-0.0030.0090.010.0060.0150.0050.023-0.0010.014-0.004-0.010.0090.010.0360.010.001-0-0.009-0.020.0070.011-00.016-0.009-0.001-0.008-0.0210.0050.0520.0020.0080.0050.011-0.0010.0090.0090.0060.0150.0270.0050.0720.0140.0150.0230.0240.0310.0260.0210.0310.0040.0110.0140.0130.0080.0190.0160.007
EPS -46.96-8.5115.1213.0513.2614.43-4.1411.8713.377.720.116.8333.57-1.419.61-5.93-13.7911.8513.9148.413.910.73-0.33-12.61-29.469.9617.04-0.6626.22-13.17-1.11-11.21-31.078.1263.621.789.574.9812.05-1.289.839.786.918.7935.786.1272.1913.6315.6923.2822.9429.5231.123.5633.194.5911.614.0811.026.3715.2512.45.11
EPS Diluted -46.96-8.5115.129.8410.0910.83-4.1411.8713.367.719.995.1833.57-1.419.61-5.93-13.7911.8513.9144.9113.910.73-0.33-12.61-29.439.9617.04-0.6626.22-13.17-1.11-11.21-31.078.1263.621.769.574.9812.05-1.289.839.786.918.7935.786.1272.1913.6315.6923.2822.9429.5231.123.5633.194.5911.614.0811.026.3715.2512.45.11
EBITDA 35544938634454033923835448822347033446925055220267241405128365109152-14223376428153170921681994.165221.747300.762203.711431.865240.153357.079146.097405.048324.848344.719370.921523.068310.323294.289279.155373.577435.96393.792402.815713.8479.141642.827244.07483.951342.601290.214204.732272.798290.71582.068
EBITDA Ratio 0.0260.0330.0290.0260.0410.0260.0180.0280.0370.0180.0370.0260.0340.020.0430.0020.0210.0190.0320.010.0280.0080.012-0.0010.0160.0270.0310.0110.0110.0070.0130.0010.0070.0160.0270.020.0420.0240.0360.0150.0390.0340.0370.0410.0530.0370.0390.0370.0490.0570.0550.0570.10.0710.0980.0380.0740.0550.0540.0390.0520.0570.017